InsidersTradesSigma
Discover the complete record of transactions filed by Kalofonos Isabel, Directeur Commercial. Director active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. The latest transaction was filed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Isabel Kalofonos serves as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. She is responsible for the company's commercial strategy and business development. Isabel brings expertise in sales management and business strategy, enabling her to drive growth initiatives. Her role is essential for achieving Crinetics' performance objectives.